These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6350084)

  • 1. Experimental hypothalamic or genetic obesity in the non-insulin-dependent diabetic rat.
    Portha B; Goursot R; Giroix MH; Nicolaïdis S; Picon L
    Diabetologia; 1983 Jul; 25(1):51-5. PubMed ID: 6350084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of imparied insulin-gene expression in occurrence of diabetes in obese rats.
    Koh G; Seino Y; Usami M; Matsuo T; Ikeda H; Yamamoto T; Tsuda K; Taminato T; Imura H
    Diabetes; 1990 Sep; 39(9):1050-6. PubMed ID: 1696558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of gonadectomy on glucose tolerance of genetically obese (fa/fa) rats: influence of sex and genetic background.
    Kava RA; West DB; Lukasik VA; Wypijewski C; Wojnar Z; Johnson PR; Greenwood MR
    Int J Obes Relat Metab Disord; 1992 Feb; 16(2):103-11. PubMed ID: 1316324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifelong sequential changes in glucose tolerance and insulin secretion in genetically obese Zucker rats (fa/fa) fed a diabetogenic diet.
    Fürnsinn C; Komjati M; Madsen OD; Schneider B; Waldhäusl W
    Endocrinology; 1991 Feb; 128(2):1093-9. PubMed ID: 1989847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caloric intake and hypothalamic neurotransmitters in Zucker rats made acutely diabetic with streptozocin.
    Svec F; Robinson P; Michel L; Bradley J; Corll C; Porter JR
    Nutr Neurosci; 2004; 7(5-6):317-24. PubMed ID: 15682928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fructose feeding on lipid parameters in obese and lean, diabetic and nondiabetic Zucker rats.
    Koh ET; Mueller J; Osilesi O; Knehans A; Reiser S
    J Nutr; 1985 Oct; 115(10):1274-84. PubMed ID: 3900313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and diabetes - a possible experimental model of maturity-onset-type diabetes.
    Inoue S; Iizuka T; Murao S
    Int J Obes; 1982; 6 Suppl 1():27-33. PubMed ID: 6214517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TNF-α blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker rats.
    Grauballe MB; Østergaard JA; Schou S; Flyvbjerg A; Holmstrup P
    J Clin Periodontol; 2015 Sep; 42(9):807-816. PubMed ID: 26257165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of insulin in food intake, weight gain and lipid deposition in the Zucker obese rat.
    Stolz DJ; Martin RJ
    J Nutr; 1982 May; 112(5):997-1002. PubMed ID: 7042936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired neural regulation of insulin secretion related to the leptin receptor gene mutation in Wistar fatty rats.
    Ohnuma H; Yamatani K; Daimon M; Igarashi M; Manaka H; Sasaki H; Kato T
    Physiol Behav; 2000 Sep; 70(5):527-32. PubMed ID: 11111007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus.
    Park SH; Marso SP; Zhou Z; Foroudi F; Topol EJ; Lincoff AM
    Circulation; 2001 Aug; 104(7):815-9. PubMed ID: 11502708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
    Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
    Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zucker and Wistar diabetic fatty rats show different response to adrenalectomy.
    Turkenkopf IJ; Kava RA; Feldweg A; Horowitz C; Greenwood MR; Johnson PR
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R912-9. PubMed ID: 1928436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of insulin secretory patterns in obese nondiabetic LA/N-cp and obese diabetic SHR/N-cp rats. Role of hyperglycemia.
    Recant L; Voyles NR; Timmers KI; Bhathena SJ; Solomon D; Wilkins S; Michaelis OE
    Diabetes; 1989 Jun; 38(6):691-7. PubMed ID: 2656338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of lean fetal hypothalamus restores hypothalamic function in Zucker obese rats.
    Fukagawa K; Knight DS; Price HV; Sakata T; Tso P
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R55-63. PubMed ID: 8760204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combination of mitiglinide with various oral antidiabetic drugs in streptozotocin-nicotinamide-induced type 2 diabetic rats and Zucker fatty rats.
    Akahane K; Ojima K; Yokoyama A; Inoue T; Kiguchi S; Tatemichi S; Takeda H; Imai Y
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1263-1271. PubMed ID: 28744906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin, insulin, and glucagon secretion from isolated perfused pancreas of obese rats.
    Seino S; Seino Y; Takemura J; Tsuda K; Kuzuya H; Ishikawa K; Shimazu T; Imura H
    Am J Physiol; 1981 Aug; 241(2):E146-50. PubMed ID: 6115583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV.
    Gram DX; Hansen AJ; Deacon CF; Brand CL; Ribel U; Wilken M; Carr RD; Svendsen O; Ahrén B
    Eur J Pharmacol; 2005 Feb; 509(2-3):211-7. PubMed ID: 15733558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.